Diprivan is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by General Injectables & Vaccines, Inc. The primary component is Propofol.
Product ID | 52584-269_bc7ce430-9a37-4654-b256-3a7ef0643e9b |
NDC | 52584-269 |
Product Type | Human Prescription Drug |
Proprietary Name | Diprivan |
Generic Name | Diprivan |
Dosage Form | Injection, Emulsion |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-03-01 |
Marketing Category | NDA / NDA |
Application Number | NDA019627 |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | PROPOFOL |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Category | NDA |
Application Number | NDA019627 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-03-01 |
Marketing End Date | 2017-01-18 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
PROPOFOL | 10 mg/mL |
SPL SET ID: | 7603f1ba-cfbd-4ec5-881a-13f4832c9893 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
52584-269 | Diprivan | Diprivan |
63323-269 | Diprivan | PROPOFOL |
65219-800 | Diprivan | PROPOFOL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DIPRIVAN 73441920 1304645 Live/Registered |
Imperial Chemical Industries PLC 1983-09-01 |